559 related articles for article (PubMed ID: 17519850)
21. Primary thrombophilia in Saudi Arabia.
Al-Jaouni SK
Saudi Med J; 2003 Jun; 24(6):614-6. PubMed ID: 12847589
[TBL] [Abstract][Full Text] [Related]
22. Thrombophilia in young patients with acute myocardial infarction.
Celik M; Altintas A; Celik Y; Karabulut A; Ayyildiz O
Saudi Med J; 2008 Jan; 29(1):48-54. PubMed ID: 18176672
[TBL] [Abstract][Full Text] [Related]
23. [Diagnosis of thrombophilia based on coagulation and genetic studies].
Bałszan-Kowalska I
Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
[TBL] [Abstract][Full Text] [Related]
24. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
[TBL] [Abstract][Full Text] [Related]
25. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A
J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
[TBL] [Abstract][Full Text] [Related]
26. Hereditary thrombophilia in ethnic Omani patients.
Pathare A; Al Kindi S; Al Haddabi H; Dennison D; Bayoumi R; Muralitharan S
Am J Hematol; 2006 Feb; 81(2):101-6. PubMed ID: 16432849
[TBL] [Abstract][Full Text] [Related]
27. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
Dahlbäck B
Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
[TBL] [Abstract][Full Text] [Related]
28. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
29. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
Kabukcu S; Keskin N; Keskin A; Atalay E
Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626
[TBL] [Abstract][Full Text] [Related]
30. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis.
Wysokinska EM; Wysokinski WE; Brown RD; Karnicki K; Gosk-Beirska I; Grill D; McBane RD
Neurology; 2008 Feb; 70(8):627-33. PubMed ID: 18285537
[TBL] [Abstract][Full Text] [Related]
31. Protein C system defects in Indian children with thrombosis.
Gupta PK; Ahmed RP; Bhattacharyya M; Kannan M; Biswas A; Kalra V; Saxena R
Ann Hematol; 2005 Feb; 84(2):85-8. PubMed ID: 15449030
[TBL] [Abstract][Full Text] [Related]
32. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for thrombophilia in extrahepatic portal vein obstruction.
Primignani M; Martinelli I; Bucciarelli P; Battaglioli T; Reati R; Fabris F; Dell'era A; Pappalardo E; Mannucci PM
Hepatology; 2005 Mar; 41(3):603-8. PubMed ID: 15726653
[TBL] [Abstract][Full Text] [Related]
34. Thrombophilia and unexplained pregnancy loss in Indian patients.
Vora S; Shetty S; Salvi V; Satoskar P; Ghosh K
Natl Med J India; 2008; 21(3):116-9. PubMed ID: 19004141
[TBL] [Abstract][Full Text] [Related]
35. [Inherited thrombophilia and arterial diseases].
Robert-Ebadi H; Boehlen F; de Moerloose P
Rev Med Suisse; 2007 Feb; 3(97):331-2, 334-5. PubMed ID: 17370730
[TBL] [Abstract][Full Text] [Related]
36. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects.
Hendler MF; Meschengieser SS; Blanco AN; Alberto MF; Salviú MJ; Gennari L; Lazzari MA
Am J Hematol; 2004 Aug; 76(4):330-7. PubMed ID: 15282664
[TBL] [Abstract][Full Text] [Related]
37. [Potential role of primary hypercoagulability and antiphospholipid antibody as a risk factor of acute pulmonary thromboembolism].
Tokuyama K; Kiuchi K; Nejima J; Takayama M; Takano T; Hayakawa H
J Cardiol; 1998 Oct; 32(4):263-8. PubMed ID: 9833233
[TBL] [Abstract][Full Text] [Related]
38. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.
Ozmen F; Ozmen MM; Ozalp N; Akar N
Ulus Travma Acil Cerrahi Derg; 2009 Mar; 15(2):113-9. PubMed ID: 19353312
[TBL] [Abstract][Full Text] [Related]
39. Hereditary deficiencies of antithrombin III, protein S, and the protein C pathway in Jordanian thrombosis patients.
Eid SS
Clin Lab Sci; 2002; 15(4):196-9. PubMed ID: 12776777
[TBL] [Abstract][Full Text] [Related]
40. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.
van Boven HH; Reitsma PH; Rosendaal FR; Bayston TA; Chowdhury V; Bauer KA; Scharrer I; Conard J; Lane DA
Thromb Haemost; 1996 Mar; 75(3):417-21. PubMed ID: 8701400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
